Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Pulmonx (LUNG) over the last 6 years, with Q3 2025 value amounting to 0.57%.

  • Pulmonx's Return on Invested Capital fell 1300.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.42% for FY2024, which is 400.0% down from last year.
  • As of Q3 2025, Pulmonx's Return on Invested Capital stood at 0.57%, which was down 1300.0% from 0.52% recorded in Q2 2025.
  • Pulmonx's 5-year Return on Invested Capital high stood at 0.16% for Q1 2021, and its period low was 0.57% during Q3 2025.
  • For the 5-year period, Pulmonx's Return on Invested Capital averaged around 0.35%, with its median value being 0.35% (2023).
  • Data for Pulmonx's Return on Invested Capital shows a peak YoY increase of 15000bps (in 2021) and a maximum YoY decrease of -3300bps (in 2021) over the last 5 years.
  • Pulmonx's Return on Invested Capital (Quarter) stood at 0.22% in 2021, then tumbled by -51bps to 0.34% in 2022, then dropped by -17bps to 0.39% in 2023, then decreased by -17bps to 0.46% in 2024, then decreased by -24bps to 0.57% in 2025.
  • Its last three reported values are 0.57% in Q3 2025, 0.52% for Q2 2025, and 0.49% during Q1 2025.